New U.S. Crown Vaccine Begins Clinical Trials: First Volunteer Inoculator Feels Good

According tomedia reports, on March 16, local time, 8 a.m., the United States began the new corona vaccine trial vaccination. Jennifer Haller, a 43-year-old woman who became the first volunteer to volunteer, appeared at the Kaiser Research Center in Seattle and said she was self-consciously part of the anti-epidemic process, feeling helpless and proud to do something to save lives.

New U.S. Crown Vaccine Begins Clinical Trials: First Volunteer Inoculator Feels Good

According to Halle, he submitted his application for voluntary vaccination a few weeks ago and was told he was on the 45-member list.

After vaccination, she needs to keep track of her body temperature and all adverse reactions and report them in a timely manner, and is expected to receive a second vaccine in four weeks, with a study cycle of up to 14 months.

The vaccine, known as mRNA-1273, is a nucleic acid vaccine developed by biotech company Moderna and funded by the National Institutes of Health (NIH), according to the data. It should be noted that the objective of the trial is to test the safety of the vaccine (whether there are side effects) and will not infect the experimenter at this stage.